IQVIA, a large contract research organization and provider of various analytics and information services to the life sciences has partnered with the U.S. Food and Drug Administration to provide agile analytics from the IQVIA CARE Project COVID-19 registry to support better understanding of how people in the community are impacted by exposure to SARS-CoV-2, the virus behind COVID-19. This accumulating registry reveals differing symptoms associated with COVID-19 as well as whether any medications or vitamin supplements individuals are consuming impact the severity of the COVID-19.
TrialSite provides a brief breakdown of this announcement.
What is the CARE Project?
A patient registry targeting those with COVID-19, it’s open to U.S.-based residents who believe they may have been exposed to SARS-CoV-2, whether they were diagnosed with COVID-19 or not. This community registry study was initiated to advance understanding of COVID-19 as experienced in community settings.
Whose leading the effort?
Nancy Dreyer, chief scientific officer for Real World Solutions
What’s the Goal?
The primary goal is to better understand how COVID-19 is affecting peopl...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).